FDA Approves Updated Warfarin (Coumadin) Prescribing Information
The U.S. Food and Drug Administration announced today the approval of updated labeling for the widely used blood-thinning drug, Coumadin, to explain that people's genetic makeup may influence how they respond to the drug.